HARVARD BIOSCIENCE, INC. Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination
HARVARD BIOSCIENCE, INC. (HBIO) reported Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination of $2.98 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-16.
Discontinued › Notes
us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination · last filed 2020-03-16
- HARVARD BIOSCIENCE, INC. contract with customer, liability, increase (decrease) for contract acquired in business combination for fiscal 2018 was $2.98M.
| Period end | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 12 month |
|---|---|
| 2018-12-31 | $2.98M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |